Event
Date: October 30, 2019
Location: Regenstrief Institute, 1101 W. 10th St., Indianapolis, IN 46202

SAM Talk: Featuring Dr. Claire Snyder, MHS, PhD

“Personalizing Care Using Patient-Reported Outcomes”

The 2019-2020 Sam Regenstrief Lecture Series

October 30, 2019  11:30AM-12:30PM

Regenstrief Institute, 1101 W. 10th St., Indiananpolis, IN 46202

Claire Snyder, MHS, PhDDr. Claire Snyder researches the quality of cancer care, with a particular focus in quality of life for cancer patients and coordination of care between cancer specialists and primary care providers.

She is investigating the use of patient-reported outcome questionnaires in routine oncology practice. This intervention involves having patients complete questionnaires regarding their functioning and well-being, providing the responses to their clinicians, and evaluating whether the questionnaires help their clinicians identify and address these quality-of-life issues.

In related research, she has developed the PatientViewpoint web tool for collecting these questionnaires and linking the results with the electronic medical record.

Dr. Snyder has also conducted multiple studies using large databases to examine the quality of care for cancer survivors — including preventive and primary care services, comorbid condition care, and cancer follow-up. A particular focus is how involvement of different physician specialties relates to whether survivors receive recommended follow-up. She is also working with a multidisciplinary team to develop survivorship care strategies at Johns Hopkins. Dr. Snyder holds a joint appointment in Health Policy and Management with the Bloomberg School of Public Health.

Related News

infographic showing findings of study

Examining how insurance coverage shapes access to kidney transplantation

Regenstrief researchers contribute to a national study highlighting differences between Medicare Advantage and traditional Medicare  For people with kidney

Tarik Yuce, MD, Jiang Bian, PhD, Serena Guo, MD, PhD, Xing He, PhD, Yu Huang, PhD

GLP-1 medications linked to greater loss of regained weight after bariatric surgery

Study involving Regenstrief researchers uses real-world evidence to evaluate an option for managing weight recurrence  People who regain weight

image of a doctor consulting with a patient

Scalable approach could improve early detection of cognitive impairment in primary care

Regenstrief-led study evaluates how existing health data and patient-reported information could help clinicians identify individuals who need further assessmentEarly

Christopher Callahan, MD

Regenstrief Institute scientist named next president and CEO of Regenstrief Foundation 

Longtime Regenstrief investigator and former IU Center for Aging Research director will assume Foundation leadership in summer 2027.  Christopher